Why the study?
Does Tongxinluo combined with mesenchymal stem cells improve cell survival and cardiac function in a swine model of acute myocardial infarction?
Does Tongxinluo combined with mesenchymal stem cells improve cell survival and cardiac function in a swine model of acute myocardial infarction?
Tongxinluo facilitates the survival and differentiation of implanted mesenchymal stem cells and improves cardiac function in a swine model of myocardial infarction.
No takes yet. Share an insight, caveat, or question.
TXL may enhance MSC therapy in swine AMI; hypothesis-generating, requires human trials before any clinical consideration.
Qian et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: